FDA Inspection 856342 — Wickliffe Pharmaceutical Inc
The FDA completed an inspection of Wickliffe Pharmaceutical Inc on December 3, 2013 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 3, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lexington, KY (United States)